https://www.selleckchem.com/pr....oducts/carfilzomib-p
05). Moderate or marked improvement at 12 months was seen in 85% of patients with soft discs and 77% of patients with osteophytes (P 0.05). Baseline-to-12-month numerical rating scale pain scores of patients with soft discs vs osteophytes had overlapping confidence intervals at each follow-up. At 12 months, very few had undergone surgery (7% of patients with soft discs, 11% of patients with osteophytes; P 0.05) or were on opioids (7% of patients with soft discs, 9% of patients with osteophytes; P 0.05). The maj
Like
Comment
Share
